Hepatic ischemic preconditioning increases portal vein flow in experimental liver ischemia reperfusion injury
Carregando...
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2014
Editora
ZHEJIANG UNIV SCH MEDICINE
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, v.13, n.1, p.40-47, 2014
Resumo
BACKGROUND: Ischemic preconditioning (IPC) has been shown to decrease liver injury and to increase hepatic microvascular perfusion after liver ischemia reperfusion. This study aimed to evaluate the effects of IPC on hemodynamics of the portal venous system. METHODS: Thirty-two rats were randomized into two groups: IPC group and control group. The rats of the IPC group underwent IPC by 10 minutes of liver ischemia followed by 10 minutes of reperfusion before liver ischemia, and the rats of the control group were subjected to 60 minutes of partial liver ischemia. Non-ischemic lobes were resected immediately after reperfusion. The animals were studied at 4 hours and 12 hours after reperfusion. Mean arterial pressure, heart rate, portal vein flow and pressure were analyzed. Blood was collected for the determination of the levels of aspartate aminotransferase, alanine aminotransferase, calcium, lactate, pH, bicarbonate, and base excess. RESULTS: IPC increased the mean portal vein flow at 4 hours and 12 hours after reperfusion. IPC recovered 78% of the mean portal vein flow at 12 hours after reperfusion. IPC decreased the levels of aspartate aminotransferase, alanine aminotransferase and lactate, and increased the levels of ionized calcium, bicarbonate and base excess at 12 hours after reperfusion. CONCLUSIONS: This study demonstrated that IPC increases portal vein flow and enhances hepatoprotective effects in liver ischemia reperfusion. The better recovery of portal vein flow after IPC may be correlated with the lower levels of transaminases and with the better metabolic profile.
Palavras-chave
ischemic preconditioning, portal vein flow, liver ischemia
Referências
- Beck-Schimmer B, 2008, ANN SURG, V248, P909, DOI 10.1097/SLA.0b013e31818f3dda
- Brunner E, 2001, STAT PAP, V42, P1, DOI 10.1007/s003620000039
- Caban A, 2006, TRANSPLANT P, V38, P196, DOI 10.1016/j.transproceed.2005.12.032
- Chouker A, 2012, TRANSPLANTATION, V94, P894, DOI 10.1097/TP.0b013e31826a9a46
- Clavien PA, 2000, ANN SURG, V232, P155, DOI 10.1097/00000658-200008000-00001
- CLEMENS MG, 1985, AM J PHYSIOL, V248, pH804
- Crenesse D, 1999, PHARMACOLOGY, V58, P160, DOI 10.1159/000028278
- Cutrin JC, 2002, FREE RADICAL BIO MED, V33, P1200, DOI 10.1016/S0891-5849(02)01017-1
- Figueira ERR, 2010, SURGERY, V147, P415, DOI 10.1016/j.surg.2009.10.018
- GASBARRINI A, 1992, J BIOL CHEM, V267, P6654
- Glanemann M, 2003, J HEPATOL, V38, P59, DOI 10.1016/S0168-8278(02)00327-6
- GLAZIER SS, 1994, J CEREBR BLOOD F MET, V14, P545
- Hanboon BK, 2010, MICROVASC RES, V80, P123, DOI 10.1016/j.mvr.2010.02.010
- HAYASHI H, 1986, J SURG RES, V40, P167, DOI 10.1016/0022-4804(86)90119-8
- Heizmann O, 2010, WORLD J GASTROENTERO, V16, P1871, DOI 10.3748/wjg.v16.i15.1871
- HORIUCHI T, 1995, ARCH SURG-CHICAGO, V130, P754
- Isozaki H, 2000, EUR J GASTROEN HEPAT, V12, P291, DOI 10.1097/00042737-200012030-00006
- Kelly DM, 2011, LIVER TRANSPLANT, V17, P1448, DOI 10.1002/lt.22424
- Klar E, 1997, TRANSPL P, V29, P362, DOI 10.1016/S0041-1345(96)00120-0
- Knudsen AR, 2013, J SURG RES, V180, pE11, DOI 10.1016/j.jss.2012.03.036
- Koti RS, 2002, LIVER TRANSPLANT, V8, P1182, DOI 10.1053/jlts.2002.36846
- LLORISCARSI JM, 1993, TRANSPLANT P, V25, P3303
- Madrahimov N, 2006, ANN SURG, V244, P89, DOI 10.1097/01.sla.0000218093.12408.0f
- Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041
- Menger MD, 1999, HEPATO-GASTROENTEROL, V46, P1452
- Montalvo-Jave EE, 2008, J SURG RES, V147, P153, DOI 10.1016/j.jss.2007.06.015
- MURRY CE, 1986, CIRCULATION, V74, P1124
- Navarro-Sabate A, 2006, LIVER TRANSPLANT, V12, P1615, DOI 10.1002/lt.20863
- Nieuwenhuijs VB, 2006, DIGEST DIS SCI, V51, P1087, DOI 10.1007/s10620-006-8014-y
- Ofluoglu E, 2006, EUR SURG RES, V38, P114, DOI 10.1159/000093300
- OSAWA M, 1994, DEV BIOL, V166, P268, DOI 10.1006/dbio.1994.1313
- Peralta C, 1999, HEPATOLOGY, V29, P126, DOI 10.1002/hep.510290104
- Peralta C, 1997, HEPATOLOGY, V25, P934, DOI 10.1002/hep.510250424
- Pine JK, 2009, LIVER TRANSPLANT, V15, P1072, DOI 10.1002/lt.21853
- Pringle JH, 1908, ANN SURG, V48, P541, DOI 10.1097/00000658-190810000-00005
- Puhl G, 2005, LIVER TRANSPLANT, V11, P555, DOI 10.1002/lt.20394
- Quireze C, 2006, J INVEST SURG, V19, P229, DOI 10.1080/08941930600778206
- Ramalho Fernando Silva, 2006, Acta Cir Bras, V21 Suppl 1, P48, DOI 10.1590/S0102-86502006000700012
- Sakon M, 2002, SURG TODAY, V32, P1
- Selzner N, 2003, J HEPATOL, V39, P55, DOI 10.1016/S0168-8278(03)00147-8
- Serafin A, 2004, HISTOL HISTOPATHOL, V19, P281
- Sindram D, 2002, J HEPATOL, V36, P78, DOI 10.1016/S0168-8278(01)00229-X
- Szijarto A, 2006, J SURG RES, V131, P150, DOI 10.1016/j.jss.2005.09.002
- Tapuria N, 2012, HPB, V14, P87, DOI 10.1111/j.1477-2574.2011.00407.x
- Tapuria N, 2008, J SURG RES, V150, P304, DOI 10.1016/j.jss.2007.12.747
- VOLLMAR B, 1994, AM J PATHOL, V145, P1421
- Yadav SS, 1999, HEPATOLOGY, V30, P1223, DOI 10.1002/hep.510300513
- Yoshizumi T, 1998, BRIT J SURG, V85, P1636
- Yuan GJ, 2005, WORLD J GASTROENTERO, V11, P1825